Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1007/s12033-021-00431-7 http://scihub22266oqcxt.onion/10.1007/s12033-021-00431-7 35091986!8799426!35091986     free     free     free Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Mol+Biotechnol 2023 ; 65 (2): 146-161 Nephropedia Template TP {{tp|p=35091986|t=2023. The Trend of CRISPR-Based Technologies in COVID-19 Disease: Beyond Genome Editing |pdf=|usr=}}{{35091986}} gab.com Text The Trend of CRISPR-Based Technologies in COVID-19 Disease: Beyond Genome Editing JO: Mol Biotechnol http://www.kidney.de/pget.php?&tw=1&pmid=35091986 #FOAvip Biotechnological approaches have always sought to utilize novel and efficient methods in the prevention, diagnosis, and treatment of diseases. This science has consistently tried to revolutionize medical science by employing state-of-the-art technologies in genomic and proteomic engineering. CRISPR-Cas system is one of the emerging techniques in the field of biotechnology. To date, the CRISPR-Cas system has been extensively applied in gene editing, targeting genomic sequences for diagnosis, treatment of diseases through genomic manipulation, and in creating animal models for preclinical researches. With the emergence of the COVID-19 pandemic in 2019, there is need for the development and modification of novel tools such as the CRISPR-Cas system for use in diagnostic emergencies. This system can compete with other existing biotechnological methods in accuracy, precision, and wide performance that could guarantee its future in these conditions. In this article, we review the various platforms of the CRISPR-Cas system meant for SARS-CoV-2 diagnosis, anti-viral therapeutic procedures, producing animal models for preclinical studies, and genome-wide screening studies toward drug and vaccine development. Twit Text FOAVip The Trend of CRISPR-Based Technologies in COVID-19 Disease: Beyond Genome Editing ????Mol Biotechnol http://www.kidney.de/pget.php?&tw=1&pmid=35091986 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=35091986 #FOAvip English Wikipedia <ref>{{Cite pmid|35091986}}</ref> The Trend of CRISPR-Based Technologies in COVID-19 Disease: Beyond Genome Editing #MMPMID35091986 Najafabadi ZY; Fanuel S; Falak R; Kaboli S; Kardar GA Mol Biotechnol 2023[Feb]; 65 (2): 146-161 PMID35091986show ga Biotechnological approaches have always sought to utilize novel and efficient methods in the prevention, diagnosis, and treatment of diseases. This science has consistently tried to revolutionize medical science by employing state-of-the-art technologies in genomic and proteomic engineering. CRISPR-Cas system is one of the emerging techniques in the field of biotechnology. To date, the CRISPR-Cas system has been extensively applied in gene editing, targeting genomic sequences for diagnosis, treatment of diseases through genomic manipulation, and in creating animal models for preclinical researches. With the emergence of the COVID-19 pandemic in 2019, there is need for the development and modification of novel tools such as the CRISPR-Cas system for use in diagnostic emergencies. This system can compete with other existing biotechnological methods in accuracy, precision, and wide performance that could guarantee its future in these conditions. In this article, we review the various platforms of the CRISPR-Cas system meant for SARS-CoV-2 diagnosis, anti-viral therapeutic procedures, producing animal models for preclinical studies, and genome-wide screening studies toward drug and vaccine development. |*COVID-19[MESH] |*Gene Editing/methods[MESH] |Animals[MESH] |COVID-19 Testing[MESH] |CRISPR-Cas Systems/genetics[MESH] |Humans[MESH] |Pandemics[MESH] |Proteomics[MESH]The Trend of CRISPR-Based Technologies in COVID-19 Disease: Beyond Gen(epmc).pdf DeepDyve Pubget Overpricing